Lee N C, Rubin G L, Ory H W, Burkman R T
Obstet Gynecol. 1983 Jul;62(1):1-6.
To study the association of pelvic inflammatory disease and various types of intrauterine devices (IUDs), data from the Women's Health Study were analyzed. The analysis included data from interviews of 622 women hospitalized with an initial episode of pelvic inflammatory disease and 2369 hospitalized control subjects reporting no history of pelvic inflammatory disease. Compared to the risk in women using no contraception, the relative risk of pelvic inflammatory disease in women currently using the Dalkon Shield was 8.3 (95% confidence limits 4.7 to 14.5). This represented a fivefold increase in risk compared to women currently using other types of IUDs. In this study, only 10% of women wearing an IUD were using the Dalkon Shield, yet they accounted for almost 20% of the excess risk of pelvic inflammatory disease occurring among all the IUD users. Most of the increased risk of pelvic inflammatory disease for women currently using other IUDs (excluding the Dalkon Shield) occurred in the first four months after insertion. These associations were not explained by differences between cases and controls in demographic variables, level of sexual activity, or medical history. The authors recommend that women still using a Dalkon Shield have it removed.
为研究盆腔炎与各类宫内节育器(IUD)之间的关联,对妇女健康研究的数据进行了分析。该分析纳入了622名因盆腔炎初发而住院的女性以及2369名报告无盆腔炎病史的住院对照对象的访谈数据。与未采取避孕措施的女性相比,当前使用达康盾(Dalkon Shield)的女性患盆腔炎的相对风险为8.3(95%置信区间为4.7至14.5)。与当前使用其他类型宫内节育器的女性相比,这意味着风险增加了五倍。在本研究中,佩戴宫内节育器的女性中只有10%使用达康盾,但她们几乎占了所有宫内节育器使用者中盆腔炎额外风险的20%。当前使用其他宫内节育器(不包括达康盾)的女性患盆腔炎风险增加的情况大多发生在插入后的前四个月。病例与对照在人口统计学变量、性活动水平或病史方面的差异无法解释这些关联。作者建议仍在使用达康盾的女性将其取出。